Maria Schoedl

Title: Maria Schoedl: Innovator in Prenatal Diagnostics

Introduction

Maria Schoedl is a notable inventor based in Baierbrunn, Germany. She has made significant contributions to the field of prenatal diagnostics, particularly in the early detection of preeclampsia. Her innovative approach has the potential to improve outcomes for pregnant individuals and their babies.

Latest Patents

Maria Schoedl holds a patent for a method titled "Means and methods applying sFlt-1/PlGF or endoglin/PlGF ratio to rule out onset of preeclampsia within a certain time period." This invention focuses on diagnostic assays for prenatal diagnosis of preeclampsia. The method involves determining the amount of specific angiogenesis biomarkers in a sample from a pregnant subject and comparing these amounts to a reference. This allows for a diagnosis with a negative predictive value of at least about 98%, indicating whether the subject is at risk for developing preeclampsia within a short time frame.

Career Highlights

Throughout her career, Maria has worked with prominent companies in the diagnostics field, including Roche Diagnostics Operations, Inc. and Roche Diagnostics GmbH. Her experience in these organizations has contributed to her expertise in developing innovative diagnostic methods.

Collaborations

Maria has collaborated with various professionals in her field, including her coworker Martin Hund. These collaborations have likely enhanced her research and development efforts, leading to her successful patent.

Conclusion

Maria Schoedl's work in prenatal diagnostics exemplifies the impact of innovation in healthcare. Her patented method for diagnosing preeclampsia represents a significant advancement in the field, potentially improving the lives of many pregnant individuals.